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Summary
A serine/threonine kinase SAD-1 in C. elegans regu-
lates synapse development. We report here the isola-
tion and characterization of mammalian orthologs of
SAD-1, named SAD-A and SAD-B, which are specifi-
cally expressed in the brain. SAD-B is associated
with synaptic vesicles and, like the active zone pro-
teins CAST and Bassoon, is tightly associated with
the presynaptic cytomatrix in nerve terminals. A short
conserved region (SCR) in the COOH-terminus is
required for the synaptic localization of SAD-B. Over-
expression of SAD-B in cultured rat hippocampal neu-
rons significantly increases the frequency ofminiature
*Correspondence: tohtsuka@med.u-toyama.ac.jpexcitatory postsynaptic current but not its amplitude.
Introduction of SCR into presynaptic superior cervical
ganglion neurons in culture significantly inhibits
evoked synaptic transmission. Moreover, SCR de-
creases the size of the readily releasable pool mea-
sured by applying hypertonic sucrose. Furthermore,
SAD-B phosphorylates the active zone protein RIM1
but not Munc13-1. These results suggest that mamma-
lian SAD kinase presynaptically regulates neurotrans-
mitter release.
Introduction
Neurotransmitter release is mediated by exocytosis in
a temporally and spatially coordinated manner. In the
classical synaptic vesicle (SV) cycling pathway, SVs
filled with appropriate neurotransmitters are reserved
as a pool, the reserve pool, and are transported to the
active zone specialized for exocytosis (Su¨dhof, 1995).
SVs, docked to the active zone and undergoing a prefu-
sion step or priming, are ready for vesicle fusion and re-
lease of neurotransmitters (Su¨dhof, 1995). These SVs
are thought to compose a vesicle pool distinguished
as the readily releasable pool (RRP) (Birks and MacIn-
tosh, 1961). After completion of these steps, SV proteins
and membrane components are retrieved by endocyto-
sis through clathrin-coated pits and recycled through
early endosomes (Cremona and De Camilli, 1997; Hay
and Scheller, 1997). SVs are the key organelle in this pro-
cess of vesicle cycling, and numerous SV proteins have
been isolated and characterized (Su¨dhof, 1995; Su¨dhof,
2004). But, it is still tempting to speculate that other reg-
ulatory proteins remain to be identified in SV docking,
priming, and fusion.
The active zone beneath the presynaptic membrane is
the principal site for Ca2+-dependent exocytosis (Landis
et al., 1988). It has been assumed that the cytomatrix at
the active zone (CAZ) is involved in determining the site
of SV fusion, but molecular mechanisms by which SVs
properly localize at the CAZ remain elusive. Presently,
the full molecular composition of the CAZ is unclear,
but several CAZ proteins, including CAST/ERC2,
ELKS, RIM1, Munc13-1, Piccolo/Aczonin, and Bassoon,
are known (Brose et al., 1995; Wang et al., 1997; tom
Dieck et al., 1998; Wang et al., 1999; Fenster et al.,
2000; Ohtsuka et al., 2002; Wang et al., 2002; Takao-
Rikitsu et al., 2004). RIM1 and Munc13-1 directly bind
to each other and are implicated in SV priming (Betz
et al., 2001). Bassoon and Piccolo are very large proteins
structurally related to each other, and Bassoon has been
shown to be involved in neurotransmitter release at ex-
citatory synapses (Altrock et al., 2003). CAST and
ELKS are novel active zone proteins highly homologous
to each other, which directly bind RIMs, Bassoon, and
Piccolo, and thought to play a role in neurotransmitter
release by binding these active zone proteins (Ohtsuka
et al., 2002; Takao-Rikitsu et al., 2004; Deguchi-Tawar-
ada et al., 2004; Deguchi-Tawarada et al., 2006). How-
ever, it is unknown how SV proteins are molecularly
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the active zone.
SAD-1 in C. elegans was first identified by genetic
screens to isolate mutations that affect SV clusters
in sensory neurons (Crump et al., 2001). Indeed, the
sad-1 mutant animal shows several unique features in
its synaptic structure and function, such as the diffuse
and disorganized distribution of SVs at synapses and
a failure to develop normal synapses in sensory axons.
Most mutations occur in the kinase domain, suggesting
that this domain of SAD-1 may play an important role in
the formation of synapses. Recently, KO mice for SAD-1
orthologs (SAD kinases) have been reported (Kishi et al.,
2005). Analysis of the mutant animals shows that mam-
malian SAD kinases are required for neural polarity that
produces axons and dendrites with distinct properties,
which is promoted at least in part by phosphorylating
the microtubule-associated protein Tau (Kishi et al.,
2005). Although these genetic studies have revealed
that SAD kinases regulate various aspects of early syn-
apse development, the biochemical properties and the
physiological functions of SAD kinases at mature synap-
ses remain largely unknown.
To test if SAD-1 is also involved in synaptic functions
such as neurotransmitter release in vertebrates, we had
isolated and characterized human orthologs of SAD-1.
Human SAD-1 comprised at least two family members,
tentatively named SAD-A and SAD-B, both of which
were specifically expressed in the brain. In the present
study, we demonstrate that SAD kinase is a novel SV-
and presynaptic cytomatrix-associated protein that reg-
ulates neurotransmitter release at mature synapses.
Results
Molecular Cloning of the SAD-1 cDNAs
To isolate a mammalian ortholog of C. elegans SAD-1,
we first searched the GenBank database with the pri-
mary sequence of SAD-1 and found several cDNA frag-
ments that were homologous to SAD-1 cDNA (data not
shown). By screening a human cDNA library, we ob-
tained two full-length cDNAs, and named them SAD-A
and SAD-B. Although SAD-A consisted of 696 aa with
a calculated molecular weight of 77,597, SAD-B con-
sisted of 778 aa with a calculated molecular weight of
85,086. Both SAD-A and SAD-B had similar domain or-
ganizations to that of C. elegans SAD-1 (Figure 1A).
The NH2-terminal serine/threonine kinase (STK) domain
was well conserved and almost identical between
SAD-A and SAD-B (94% identity). In addition, two short
conserved regions (SCR1 and SCR2) (Crump et al., 2001)
existed in the middle and COOH-terminal regions.
Tissue Distribution of SAD-B
Northern blot analysis showed that thew3.5 kb band of
SAD-B was specifically detected in the brain (Fig-
ure S1A). SAD-A was also specifically expressed in the
brain (data not shown). Both the proteins were structur-
ally related to each other and specifically expressed in
the brain, and then we focused on SAD-B. We next pro-
duced a polyclonal antibody (Ab) against SAD-B that
specifically detected SAD-B, but not SAD-A (Fig-
ure S1B). Tissue distribution analysis showed that the
anti-SAD-B Ab recognized a protein band of w90 kDain rat brain, but not in other rat tissues (Figure 1B),
indicating that SAD-B is specifically expressed in the
brain.
Localization of SAD-B at Synapses
Western blotting revealed that SAD-B was expressed in
various rat brain regions, including the hippocampus,
the cortex, the cerebellum, the amygdala, and the olfac-
tory bulb (data not shown). Consistently, a widespread
immunoreactivity for SAD-B was detected throughout
mouse brain (Figure S1C). We then examined in more
detail the localization of SAD-B in mouse hippocampus
and cerebellum by immunohistochemistry and com-
pared the staining pattern of SAD-B with that of synap-
tophysin. In the CA3 region of the hippocampus, the im-
munofluorescence signal for SAD-B overlapped with
that of synaptophysin (Figure 1C). In the cerebellum,
SAD-B showed a similar signal pattern in the molecular
and granular cell layers, which colocalized with that of
synaptophysin (Figure 1D). Note that the signal of
SAD-B was also detected in the cell bodies. These re-
sults suggest that SAD-B is relatively concentrated
and localized at the synapses.
In primary cultured rat hippocampal neurons, SAD-B
showed a dot-like signal along the dendrites that colo-
calized well with that of synaptophysin, although immu-
noreactivity of SAD-B was slightly detected in the cell
body and dendrites (Figure 1E, top). In addition, the sig-
nal for SAD-B partially colocalized with those of the ac-
tive zone protein Bassoon and the well-known postsyn-
aptic density (PSD) protein PSD-95/SAP90 (Cho et al.,
1992; Kistner et al., 1993) (Figure 1E, middle and bot-
tom). These results also support the notion that SAD-B
is a synaptic protein.
Association of SAD-B with Synaptic Vesicles
and the Presynaptic Cytomatrix
We used immunoelectron microscopy to examine the
subsynaptic localization of SAD-B. Immunoelectron mi-
croscopic analysis of cultured neurons showed that im-
munogold-labeled signals of SAD-B were mainly de-
tected in presynaptic nerve terminals (Figure 2A). The
signal of SAD-B appeared to be associated with SVs. In-
terestingly, some of the signals were detected very
close to the presynaptic plasma membrane. Note that
several signals of SAD-B were also detected in the den-
drites (Figure 2A) and cell bodies (data not shown).
These results further support the notion that SAD-B is
mainly present in the presynaptic nerve terminals.
Consistent with these results, subcellular distribution
analysis in rat brain showed that SAD-B was relatively
concentrated in the crude synaptic vesicle (CSV) frac-
tion (Figure 2B), which was similar to that for synapto-
physin. Further fractionation of the CSV fraction pro-
duced SV1-SV4 fractions, of which the SV1 fraction
contains the most pure sample of SVs (Mizoguchi
et al., 1989). SAD-B and synaptophysin were mainly de-
tected in the SV1 and SV2 fractions (Figure 2C). In addi-
tion, the SVs immunoisolated by an anti-synaptotagmin
I Ab contained synaptophysin and SAD-B (Figure 2D,
left). Under the same conditions, the SVs immunoiso-
lated by the anti-SAD-B Ab contained synaptophysin
and synaptotagmin I (Figure 2D, right). Therefore, these
results suggest that SAD-B is an SV-associated protein.
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263Figure 1. Molecular Structure and Tissue
Distribution of SAD-B
(A) Comparison of structures between SAD-B,
SAD-A, and CeSAD-1.
(B) Tissue distribution. The homogenates of
various rat tissues (20 mg of protein each)
were analyzed by Western blotting using the
anti-SAD-B Ab.
(C–E) Immunofluorescence microscopy. (C)
The CA3 region of mouse hippocampus.
The sections were double stained with the
anti-SAD-B and anti-synaptophysin Abs.
SR, stratum radiatum; SL, stratum lucidum;
SP, stratum pyramidale. (D) Mouse cerebel-
lum. The sections were double stained with
the anti-SAD-B and anti-synaptophysin Abs.
Gr, granular layer; Pj, Purkinje cell layer; Mo,
molecular layer. Bars, 20 mm. (E) Localization
of SAD-B in cultured neurons. Neurons at 21
days of culture were fixed and double stained
with the anti-SAD-B Ab and the anti-synapto-
physin, the anti-Bassoon, or the anti-PSD-95/
SAP90 Ab. Bars, 10 mm. The results are repre-
sentative of three independent experiments.In addition, SAD-B and synaptophysin were detected
in the crude synaptic membrane (CSM) fraction (Fig-
ure 2B), suggesting that both proteins were associated
with docked SVs. Moreover, like the active zone protein
CAST and the PSD protein NMDA receptor, SAD-B was
concentrated in the biochemically isolated PSD fraction,
whereas synaptophysin was almost completely absent
from this fraction (Figure 2B). The biochemically isolated
PSD fraction is known to contain not only PSD proteins
but also the active zone proteins CAST, RIMs, Bassoon,
and Piccolo (Cases-Langhoff et al., 1996; Langnaese
et al., 1996; Wang et al., 1997; tom Dieck et al., 1998;
Phillips et al., 2001; Ohtsuka et al., 2002). Thus, the sig-
nal of SAD-B in the PSD fraction appears to correspond
to that of SAD-B, which localized close to the presynap-
tic membrane (see Figure 2A). In addition, SAD-B wasresistant to solubilization by CHAPS, a zwitter ionic de-
tergent, and NP-40 and Triton X-100, nonionic deter-
gents, in contrast to synaptophysin (Figure 2e). This bio-
chemical property of SAD-B was similar to those of the
CAZ proteins CAST (Figure 2E, bottom) (Ohtsuka et al.,
2002), RIM1, Bassoon, and Piccolo. But, unlike CAST,
SAD-B was slightly solubilized with the nonionic deter-
gents, which might be at least partly consistent with
the immunorectivity for SAD-B in the cell bodies and
dendrites of neurons (see Figures 1E and 2A) and its as-
sociation with SVs. At any rate, these results suggest
that some portions of SAD-B are tightly associated
with the presynaptic cytomatrix.
We next performed a cell biological analysis to con-
firm the tight association of SAD-B with the presynaptic
cytomatrix. To do this, we briefly treated cultured
Neuron
264Figure 2. Subcellular Distribution of SAD-B in Neurons
(A) Immunoelectron microscopy. Neurons were reacted with the anti-SAD-B Ab, incubated with immunogold particles (1.4 nm) conjugated with
goat IgG against rabbit IgG and silver-enhanced, followed by electron microscopic analysis. Bars, 500 nm.
(B) Subcellular distribution. The homogenate of rat brain was subjected to subcellular fractionation. An aliquot of each fraction (5 mg of protein
each) was analyzed by Western blotting with the indicated Abs. Hom, homogenate; S1, crude synaptosomal fraction; P2, crude membrane frac-
tion;P2A, myelin fraction;P2B, ER, Golgi complex and membranes fraction;P2C, synaptosomal fraction;P2D, mitochondria fraction;CSV, crude
synaptic vesicle fraction; CSM, crude synaptic membrane fraction; PSD, postsynaptic density fraction; S, 1% Triton X-100-soluble fraction of
PSD; P, 1% (w/v) Triton X-100-insoluble fraction of PSD. NMDAR2, the NMDA receptor 2B; Syn, synaptophysin.
(C) Subcellular distribution in the CSV fraction. An aliquot of each fraction (2 mg of protein each) was analyzed by Western blotting with the in-
dicated Abs. SV1, contained SVs almost free synaptic plasma membranes; SV2, contained SVs contaminated with some synaptic plasma mem-
branes; SV3, contained mainly synaptic plasma membranes contaminated with SVs; SV4, contained synaptic plasma membranes with almost
free SVs. Sytx, Syntaxin1A.
(D) Immunoaffinity purification of SAD-B-associated vesicle. The vesicle fraction was immunoaffinity purified with anti-Myc, anti-synaptotagmin I,
control rabbit IgG, or anti-SAD-B Ab from P2 fraction. Each immunoaffinity-purified fraction was analyzed by Western blotting with the indicated
Abs. StgI, synaptotagmin I.
(E) Solubility of SAD-B, synaptophysin, and CAST by various detergents. Proteins were extracted from the crude membrane fraction with the
indicated detergents and then separated into the soluble and pellet fractions. An aliquot (10 ml) of each fraction was analyzed by Western blotting
with the indicated Abs. P, pellet fraction; S, soluble fraction. The results are representative of three independent experiments.neurons with Triton X-100 before paraformaldehyde-
fixation and then stained synaptic proteins such as syn-
aptophysin, SAD-B, CAST, and Bassoon. Under such
conditions, synaptophysin, a Triton X-100-soluble SV
protein, was shown to be almost completely extracted,
whereas Bassoon was hardly extracted (Dresbachet al., 2003). Consistent with these observations, synap-
tophysin was completely washed out (Figure 3A),
whereas Bassoon was preserved (Figure 3B). Like Bas-
soon, another prominent CAZ protein CAST was also
preserved (Figures 3A and 3B). Under the same condi-
tions, SAD-B was indeed preserved like these CAZ
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265Figure 3. Association of SAD-B with the CAZ
(A–D) Immunofluorescence microscopy.
Neurons at 21 days of culture were fixed
with paraformaldehyde after 0.1% (w/v) Tri-
ton X-100 extraction and stained with indi-
cated Abs. Bars, 5 mm.
(E) Immunoelectron microscopy. Bars, 100
nm. The results are representative of three in-
dependent experiments.proteins (Figures 3C and 3D). Moreover, immunoelec-
tron microscopic analysis with these Triton X-100-
treated cultured neurons revealed that SAD-B was asso-
ciated with the presynaptic cytomatrix (Figure 3E).
These results suggest that SAD-B is associated with
SVs and incorporated into and tightly associated with
the presynaptic cytomatrix.
Mechanism of Localization of SAD-B in Neurons
We next examined the mechanism of the localization of
SAD-B in primary cultured rat hippocampal neurons by
expressing their various mutants. The various SAD-B
mutants are schematically shown in Figure 4A. We first
expressed the full-length of SAD-B. EGFP-SAD-B-1 co-
localized with synaptophysin at the synaptic boutons
(Figure 4B). EGFP-SAD-B-2, which had only the STK do-
main, showed diffuse distribution in cultured neurons
(data not shown). In contrast, EGFP-SAD-B-4, whichlacked the STK domain but had two SCRs, colocalized
with synaptophysin (Figure 4B). EGFP-SAD-B-5, which
lacked the STK domain but had SCR2, colocalized
with synaptophysin (data not shown). EGFP-SAD-B-6,
which had SCR2, colocalized with synaptophysin,
whereas EGFP-SAD-B-3, which lacked the COOH termi-
nus containing SCR2, showed a diffuse distribution (Fig-
ure 4B). These results suggest that SAD-B synaptically
localizes in cultured neurons through its COOH-terminal
region containing SCR2.
Involvement of SAD-B in Neurotransmitter Release
in Primary Cultured Rat Hippocampal Neurons
The unique localization of SAD-B on SVs and at the pre-
synaptic cytomatrix suggests that SAD-B is involved in
neurotransmitter release in the nerve terminals. To test
this, we examined the role of SAD-B in neurotransmis-
sion by transfection of the SAD-B constructs in primary
Neuron
266Figure 4. Localization of SAD-B in Primary
Cultured Rat Hippocampal Neurons
(A) Various EGFP-tagged constructs of SAD-B.
(B) Localization of the SAD-B constructs in
neurons. Neurons at 7 or 8 days of culture
were transfected with the indicated expres-
sion vectors and stained with anti-synapto-
physin Ab at 10 days of culture. Bars, 10
mm. The results are representative of three in-
dependent experiments.cultured rat hippocampal neurons, followed by electro-
physiological studies. The kinase domain of SAD-B be-
longs to those of other STKs such as cAMPKa and
MARK1 (Hanks et al., 1988; Drewes et al., 1997). In these
kinases, a conserved lysine residue located in the ATP
binding site is essential for their kinase activity (Hanks
et al., 1988). In fact, the substitution of the lysine residue
to arginine abolishes the kinase activity of these kinases
(Drewes et al., 1997; Zhong et al., 1997). This lysine res-
idue is also conserved as lysine 63 in SAD-B (Figure 5A).
We thus substituted the lysine residue of SAD-B to the
arginine residue (Figure 5A) to obtain a kinase-deficient
mutant of SAD-B (EGFP-SAD-B-1K63R) (see Figure 8).After transfecting the cultured neurons with EGFP-
SAD-B-1wild and EGFP-SAD-B-1K63R, we measured min-
iature excitatory postsynaptic current (mEPSC) by
blocking sodium-channel-mediated action potential ac-
tivity with tetrodotoxin (TTX) under whole-cell voltage
clamp. Overexpression of EGFP-SAD-B-1 significantly
increased the frequency of mEPSC by approximately
6-fold (n = 8 for EGFP-SAD-B-1, EGFP-SAD-B-1 versus
control, p < 0.01), whereas control EGFP or EGFP-SAD-
B-1K63R had no effect on the frequency (Figures 5B and
5C). No significant change of its amplitude was ob-
served by overexpression of all the constructs (Fig-
ure 5D). In addition, no significant difference in the
SAD Regulates Neurotransmitter Release
267Figure 5. Effect of the Full-Length and Ki-
nase-Negative Mutant of SAD-B on Neuro-
transmitter Release
(A) Alignment of the sequence of conserved
ATP binding sites in several protein kinases
and point-mutated SAD-BK63R. The ATP
binding sites were shaded in black. Black un-
derline indicates the point-mutated residue.
(B) Representative recording of AMPA recep-
tor-mediated mEPSCs from the neurons
transfected with indicated constructs.
(C) mEPSC frequency in the neurons trans-
fected with indicated constructs.
(D) mEPSC amplitude in the neurons trans-
fected with indicated constructs.
(E) Representative recording of AMPA recep-
tor-mediated mEPSCs at 10 mM external
Ca2+ from neurons transfected with the indi-
cated constructs.
(F) mEPSC frequencies at 10 mM extracellu-
lar Ca2+ in neurons transfected with the indi-
cated constructs. Asterisk, p < 0.01. Data
(C, D, and F) were expressed by mean 6
SEM.average rise time and decay time of mEPSC was de-
tected (data not shown), suggesting that SAD-B may
not be involved in the fusion of SVs.
It is possible that the absence of significant effects on
mEPSC frequency upon overexpression of dominant-
negative EGFP-SAD-B-1K63R might be due to the low
basal level of spontaneous transmitter release occurring
at a normal Ca2+ concentration (Figures 5B and 5C). We
then performed the same experiment at 10 mM external
Ca2+, which enhanced basal mEPSC frequencies. Al-
though no significant change in amplitude, rise time, or
decay time was observed under these conditions (data
not shown), the mEPSC frequency was increasedw1.8-
fold by overexpression of EGFP-SAD-B-1wild (n = 11 for
EGFP-SAD-B-1wild versus control, p < 0.01) and was sig-
nificantly decreased by overexpression of EGFP-SAD-
B-1K63R (w0.6-fold) (Figure 5E and 5F). These results
suggest that the SAD-B kinase activity is involved inthe regulation of SV release probability. To confirm
neurotransmitter specificity of the observed effects,
mEPSCs were abolished with 50 mM CNQX (data not
shown), indicating that SAD-B regulates AMPA recep-
tor-mediated neurotransmission by a presynaptic
mechanism.
Because SAD-1 in C. elegans has been shown to be
involved in synapse formation, such as the clustering
of SVs (Crump et al., 2001), we examined whether such
a developmental effect may be a basis for the SAD-B
function in neurotransmitter release. We coexpressed
SAD-B with synaptophysin-EGFP or EGFP-Bassoon
and examinined the change of the size and number of
the EGFP and endogenous signal: we assumed that
the staining signals for synaptophysin and Bassoon re-
flect those of SVs and active zones, respectively. A
quantitative analysis showed no significant change in
the size and number of synaptophysin or Bassoon
Neuron
268immunoreactive puncta (Figures S3 and S4). Thus, de-
velopmental changes do not appear to contribute to
the SAD function in neurotransmitter release.
Mechanism of Action of SAD-B
in Neurotransmitter Release
We next examined the mode of action of SAD-B at
a well-characterized cholinergic synapse formed be-
tween cultured rat superior cervical ganglion (SCG) neu-
rons (Mochida et al., 1994, 1995, 1996; Ilardi et al., 1999).
This is an ideal system because proteins can be intro-
duced into the relatively large (30–40 mm) presynaptic
cell bodies by microinjection, the injected proteins can
rapidly diffuse to nerve terminals forming synapses
with adjacent neurons, and the effect on stimulated re-
lease of acetylcholine can be accurately monitored by
recording excitatory postsynaptic potentials (EPSPs)
evoked by action potentials in presynaptic neurons. In
SCG neurons, SAD-B showed dot-like signals that colo-
calized well with those of synaptophysin and Bassoon
(Figure S2), indicating that SAD-B localizes at synapses
formed between cultured SCG neurons, together with
other synaptic proteins.
To test the presynaptic function of SAD-B in this sys-
tem, we then prepared the recombinant protein of SCR2,
which might affect SAD-B function in neurons, because
this region appears to play a role in localizing SAD-B at
synapses in neurons (Figure 4). In addition we prepared
another GST-tagged protein, as a control, from an un-
conserved region (S1) (aa 450–521), which is located be-
tween SCR1 and SCR2 in SAD-B. Microinjection of
SCR2 into presynaptic SCG neurons significantly in-
hibited synaptic transmission (Figures 6A, 6B, 6F, and
6G), without changing EPSP waveform (Figure 6A). The
amplitude of EPSP recorded every 20 s at 0.05 Hz
decreased by 236 6 8.3% (n = 5) at 70 min after injec-
tion of SCR2. In contrast, neither the S1 nor GST, as
a control, produced any significant decrease in the
EPSP amplitude (Figures 6D and 6E) (21.7 6 5.6%, n =
5, and 24.4 6 8.1%, n = 5, respectively) (p < 0.01 un-
paired t test at 70 min after the injection of SCR2 versus
S1 or GST). The decrease in EPSP amplitude by SCR2 (1
or 10 mM) recovered to control preinjection levels within
80 min (Figures 6H and 6I), indicating that the SCR2 ef-
fect was concentration dependent and reversible.
Next, we raised a polyclonal Ab against the SCR2 do-
main of SAD-B and microinjected the IgG fraction into
SCG neurons. The anti-SCR2 Ab specifically impaired
neurotransmission, whereas control rabbit IgG had no
effect (Figure 6J). Taken together, these results provide
functional evidence that SCR2 of SAD-B may play a role
in neurotransmitter release.
We examined the possible involvement of SAD-B in an
SV-trafficking step regulating the RRP. To test this, we
accelerated the cycling of SVs in presynaptic terminals
by employing presynaptic stimulation with a higher fre-
quency. Stimuli at 0.2 Hz produced no significant poten-
tiation of the SCR2-dependent reduction in EPSP
(Figure 6C). At 70 min after the injection of SCR2, the
EPSP amplitude was reduced by 234 6 7.8% (n = 5).
This value, a decrease of 34%, was not significantly dif-
ferent from the 36% reduction with 0.05 Hz stimulation
(p = 0.48, unpaired t test at 70 min after the injection of
SCR2 with 0.2 Hz versus 0.05 Hz stimulation). In anotherseries of experiments, repetitive stimulation (0.05 Hz)
was stopped for 20 min after injection of SCR2. When
stimulation was started again, the EPSP amplitude
was smaller than that observed before stimulation was
interrupted (Figures 6K and 6L). These results suggest
that the reduction of neurotransmitter release by injec-
tion of SCR2 is independent of presynaptic firing history
or the activity-dependent cycling of SVs in presynaptic
nerve terminals. Next, we employed a paired-pulse stim-
ulation protocol to ask whether SCR2 interferes with the
releasable vesicles at the active zone within short inter-
stimulus intervals of neurotransmitter release (Stevens
and Wang, 1995) elicited by successive evoked action
potentials. In this experiment, EPSPs evoked with vari-
ous time intervals between two action potentials were
recorded both before and 15–35 min after SCR2 injec-
tion. The amplitudes of the first and the second EPSP
were reduced after SCR2 injection in the absence of pre-
synaptic activity (Figures 7A and 7B). In the presence of
SCR2, the second EPSP amplitude did not recover to
the initial amplitude (Figures 7B and 7C). These results
suggest that SCR2 perturbations reduce the amount of
releasable transmitter at the active zone independently
of the presynaptic activity and the amount of secondary
releasable transmitter within a short interval, indicating
that the major effect of SCR2 most likely involves
a step specifying the number, priming, or sensitivity of
vesicles in the RRP at the active zone, and/or release
probability and quantal size (Chen et al., 2004).
To confirm the role of SAD-B in regulation of the RRP,
we examined the effect of SAD-B on the size of the RRP.
In this experiment, we repeatedly applied hypertonic su-
crose solution to selectively release the functionally de-
fined RRP (Rosenmund and Stevens, 1996). Focal puff-
application of 0.5 M sucrose to a synaptic pair induced
small EPSPs in postsynaptic neurons (Figure 7D). The
integral value of the small EPSPs with hypertonic chal-
lenge reflects the size of the RRP (Figure 7D); and there-
fore, changes in the integral value indicate changes in
the size of the RRP (Figures 7E and 7F). Injection of
SCR2 reduced the integral by 225 6 8.4% (n = 7) at 27
min after starting SCR2 injection (p < 0.03, paired t test
before versus at 27 min after the injection). As a control,
S1 produced no significant reduction of the small EPSPs
integral (p = 0.39, paired t test before versus at 27 min),
suggesting that the decrease in size of the RRP by
the SCR2 is specific (p < 0.05, unpaired t test at 27 min
after SCR2 versus S1 injection). Taken together, these
results suggest that SAD-B is involved in control of the
RRP size.
Kinase Activity of SAD-B
The findings so far led us to speculate that SAD kinase
might phosphorylate a substrate(s) in the nerve terminal
for regulation of neurotransmitter release. Such candi-
dates would be the active zone protein/vesicle priming
factor RIM1 and/or Munc13-1, because these active
zone proteins directly interact with each other and are
involved in the priming step during neurotransmitter re-
lease (Betz et al., 2001), and SAD-B is associated with
the presynaptic cytomatrix at the active zone (in this
study). Thus, to examine whether SAD kinase phosphor-
ylates RIM1 and Munc13-1, we first attempted to char-
acterize the kinase activity of SAD-B. For this, we
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SCR2, GST, or S1 was introduced into presynaptic SCG neurons at t = 0 (100 mM each in the injection pipette, except for [H]). Presynaptic neurons
were stimulated every 20 s or every 5 s. (A) EPSPs from a representative experiment with SCR2 injection at the indicated times. EPSP amplitudes
from four (K and L) or five experiments were normalized and averaged. Mean6 SEM values (B–E) and mean values smoothed by an eight-point
moving average algorithm are plotted (F, H, J, and K). (B) SCR2 injection at 0.05 Hz. (C) SCR2 injection at 0.2 Hz. (D) GST injection at 0.05 Hz. (E) S1
injection at 0.05 Hz. (F) Smoothed mean values plotted in (B)–(E). (G) Decrease in the EPSP amplitude at 40 min. Asterisk, p < 0.01, unpaired t test,
SCR2 injection with 0.05 Hz stimulation versus GST or S1 injection, respectively. p = 0.53, unpaired t test, SCR2 injection with 0.05 Hz versus 0.2
Hz stimulation. (H) Injection of various concentrations of SCR2 at 0.05 Hz. (I) Decrease in the EPSP amplitude at 45 min. Asterisk, p < 0.05, un-
paired t test, 1 mM SCR2 injection versus 10 or 100 mM injection, respectively. (J) Injection of anti-SCR2 Ab or control IgG (1.25 mg/ml in the in-
jection pipette) at 0.1 Hz. (K) SCR2 injection (100 mM) in which stimulation at 0.05 Hz was stopped for 20 min, from 15 to 35 min, after peptide
injection. (L) Averaged EPSP amplitudes recorded at 14–15 min and 35–36 min after SCR2 injection.overexpressed Myc-tagged full-length of SAD-B (Myc-
SAD-Bwild or K63R; see Figure 5A) into HEK293 cells. As
shown in Figure 8, a1, Myc-SAD-Bwild immunoprecipi-
tated with the anti-Myc Ab was autophosphorylated,
whereas Myc-SAD-BK63R was slightly phosphorylated.
The similar result was obtained in the case of its kinasedomain (Myc-SAD-B KDwild or K63R; see Figure 4A)
(Figure 8Aa1).
As to the slight phosporylation of Myc-SAD-BK63R
and -SAD-B KDK63R, we assume that this is due to the
contamination of a kinase(s) in immunoprecipitation ly-
sates from HEK293 cells, which may phosphorylate
Neuron
270Figure 7. Effect of SAD-B on the Readily Releasable Pool
SCR2 or S1 was introduced into presynaptic SCG neurons at t = 0 (100 mM each in the injection pipette). (A–C) Estimation of the readily releasable
vesicles at the active zone after a single action potential during paired pulse stimulation. (A) EPSPs elicited by two consecutive action potentials
from one representative experiment before and after SCR2 injection. (B and C) Ratio of EPSP amplitudes injected with SCR2 (B) and S1 (C) is
plotted against the interval between the two stimuli (n = 4, asterisk, p < 0.05, paired t test, before versus after SCR2 injection). Data were ex-
pressed by mean6 SEM. (D–F) The RRP size was measured by puff application of 0.5 M sucrose for 2 s every 5 min. (D) Responses to sucrose
applications from one representative experiment with SCR2. Recordings at 3 min before and at 17 and 47 min after the injection with SCR2 are
illustrated. (E and F) Normalized and averaged integral values of the sucrose responses injected with SCR2 (E) and S1 (F) are plotted (n = 7, mean
6 SEM). Asterisk, p < 0.05, paired t test, before versus after SCR2 injection.the mutant protein, causing the background. To clarify
this issue, we employed two approaches. First, we pro-
duced another mutant of SAD-B in which threonine 189
and serine 193 were substituted to alanine. These resi-
dues were conserved in the related kinase PAR1/
MARK and shown to be autophosphorylated (Drewes
et al., 1997). Indeed, the mutant of SAD-B (Myc-SAD-B
KDT189A/S193A) was not phosphorylated (Figure 8Aa2).
Second, we produced the maltose binding protein
(MBP)-tagged kinase domain of SAD-B (MBP-SAD-B
KDwild and K63R) in E. coli. MBP-SAD-B KDwild was clearly
autophosphorylated, whereas MBP-SAD-B KDK63R was
not (Figure 8B). In this case, no background was de-
tected. These results clearly show that SAD-B has a ki-
nase activity and the mutant is kinase-deficient and
then provide another line of evidence that the kinase ac-
tivity of SAD-B plays a role in neurotransmitter release
(see Figure 5).
Phosphorylation of RIM1 by SAD-B
We next produced and purified recombinant GST-fusion
proteins that cover RIM1 in overlapping fragments (frag-
ments A–E) (Figure 8C). These recombinant proteins
were incubated with 32P-g-ATP and MBP-SAD-B KDwild
or -SAD-B KDK63R and were subjected to SDS-PAGE,
followed by autoradiography and Coomassie Brilliant
Blue staining (Figure 8D). Under the conditions in which
MBP-SAD-B KDwild, but not the MBP-SAD-B KDK63R,
was autophosphorylated, GST-RIM1 containing
COOH-terminal region (E2), but not the other GST-fusion
proteins, was specifically phosphorylated (Figure 8D,top; Figure S5). To confirm this, we further divided the
E2 region into five fragments (Figure 8C). Then, GST-
RIM1 E2-1 (aa 1135–1206), but not the other fusion pro-
teins, was phosphorylated (Figure 8E; Figure S6). These
results suggest that SAD-B has a potency to phosphor-
ylate RIM1, a region near COOH-terminal C2B domain.
Moreover, we finally tested whether SAD-B phosphory-
lates Munc13-1, but none of the recombinant proteins
that cover Munc13-1 in overlapping fragments were
phosporylated (Figure S7). Thus, these results suggest
that SAD-B specifically phosphorylates RIM1 but not
Munc13-1 at least in vitro.
Discussion
SAD Kinase as an SV-Associated Protein
The following lines of evidence led us to conclude that
SAD-B is a novel SV-associated protein: (1) like the
prominent SV protein synaptophysin, SAD-B is concen-
trated in the SV1 and SV2 fractions; (2) in the mouse hip-
pocampus and cerebellum, SAD-B colocalizes with syn-
aptophysin; (3) in primary cultured rat hippocampal
neurons, endogenous SAD-B colocalizes with synapto-
physin; (4) SAD-B is observed by electron microscopy to
localize at nerve terminals and is associated with SVs;
and (5) SVs immunoisolated by the anti-synaptotagmin
I Ab-coupled beads contain SAD-B, and vice versa.
By transfection analysis with cultured hippocampal
neurons, we show here that SCR2 may play a role in lo-
calizing SAD-B at synapses, although it remains un-
known whether SCR2 is required for its association
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(A) Autophosphorylation of SAD-1B. Myc-tagged SAD-Bwild or K63R
(a1) or Myc-tagged kinase domain of SAD-Bwild, K63R, or T189A/S193A
(a2) was transfected into HEK293 cells. The cells were extracted
with Triton X-100 and immunopreciputated by the anti-Myc Ab.
The immunoprecipitates were assayed for autophosphorylation.
The amount of the Myc-tagged proteins immunoprecipitated was
confirmed by silver staining (SS). Auto, autoradiography. Asterisk in-
dicates the heavy chain of the anti-Myc Ab.
(B) Autophosphorylation of bacterially expressed kinase domain
of SAD-B. Amylose resin beads containing MBP-kinase domain
of SAD-Bwild or K63R were assay for autophosphorylation. MBP-
SAD-B KDwild, but not MBP-SAD-B KDK63R, was specifically phos-
phorylated. KD, kinase domain; Auto, autoradiography; CBB,with SVs. However, if this is in the case, because SCR2
has no posttranslational modification sites, it is likely
that SAD-B is associated with SVs through directly bind-
ing to a SV protein(s) on SVs via SCR2 or in a manner
similar to that of synapsin; it is thought to be associated
with SVs through its NH2-terminal domain, which di-
rectly binds phospholipid moeties of SV membranes
(Hosaka et al., 1999). Currently, we have not isolated
binding proteins for SCR2, but the identification and
characterization of such candidates in future research
would allow further insight into the molecular mech-
anisms underlying the association of SAD kinase
with SVs.
Tight Association of SAD Kinase
with the Presynaptic Cytomatrix
Our biochemical and immunofluorescence studies with
pretreatment by Triton X-100 show that SAD-B is also
tightly associated with the presynaptic cytomatrix.
This property is similar to those of CAZ proteins, such
as CAST, Bassoon, and Piccolo (Cases-Langhoff et al.,
1996; tom Dieck et al., 1998; Ohtsuka et al., 2002). Immu-
noelectron microscopic analysis further demonstrates
that some portions of SAD-B in the nerve terminal local-
ize to the vicinity of the presynaptic plasma membrane
(Figure 2A). Thus, our present studies suggest that
SAD-B is an SV-associated protein that has the potency
to localize to and be tightly associated with the presyn-
aptic cytomatrix. To our knowledge, SAD-B is the first ki-
nase that shows these unique biochemical features and
cell biological localization at synapses. But, the mode of
association of SAD-B with the presynaptic cytomatrix
remains unknown as is the case for its association
with SVs described above.
Involvement of SAD Kinase in Neurotransmitter
Release
In the present study, we have also demonstrated that
SAD-B is involved in the regulation of neurotransmitter
release in mammalian neurons. Overexpression of
Coomassie Brilliant Blue. Asterisk indicates a heat shock protein.
Arrowhead indicates MBP-SAD-B KD.
(C) Various fragments of RIM1. These fragments were produced as
GST-fusion proteins.
(D) Analysis of phosphorylation of RIM1 by SAD-B. Various recombi-
nant proteins that cover the entire RIM1 sequence were incubated
with 32P-g-ATP and MBP-SAD-B KDwild or K63R and subjected to
SDS-PAGE, followed by autoradiography and Coomassie Brilliant
Blue staining (CBB) as indicated. The results of the RIM1 fragments
(A, aa 1–398; B, aa 378–516; D2, aa 838–907; E1, aa 890–1152; and
E2, aa 1136–stop) were shown, whereas the results of the others
(C and D1, aa 748–846) were shown in Figure S5. W, wild; K, K63R;
Auto, autoradiography. Arrowheads indicate the position of MBP-
SAD-B KDwild or K63R. Arrows indicates the position of GST-RIM1
E2 protein. Asterisks indicate each recombinant protein of RIM1.
(E) Analysis of phosphorylation of various fragments within RIM1 E2
region. To narrow the phosphorylated region, various recombinant
proteins that cover the RIM1 E2 region were incubated with 32P-g-
ATP and MBP-SAD-B KDwild and subjected to SDS-PAGE, followed
by autoradiography. The amount of these recombinant proteins was
confirmed by Coomassie Brilliant Blue staining in Figure S6. Under
the conditions in which GST-RIM1 E2 was phosphorylated, GST-
RIM1 E2-1, but not the other recombinant proteins, was specifically
phosphorylated. The phosphorylated site is located in the region
(1135–1206 aa) near COOH-terminal C2B domain (C).
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ing mEPSC amplitude recorded in primary cultured rat
hippocampal neurons. Overexpression of SAD-B lack-
ing its kinase activity decreases mEPSC frequency, sup-
porting the conclusion that SAD-B kinase activity
appears to be important for the regulation of neurotrans-
mitter release. There may be a number of physiological
and possible nonphysiological substrates for overex-
pressed SAD kinase. However, we identified SAD-B
phosphorylation of the vesicle priming factor RIM1,
but not Munc13-1. This fact would seem to indicate
that SAD-B is phosphorylating substrates specifically
within the neurotransmitter release apparatus with
which SAD-B colocalizes. Furthermore, considering
the unique localization of SAD-B at the presynaptic cy-
tomatrix, it is possible that SAD-B is well positioned to
phosphorylate RIM1 in vivo consistent with the in vitro
data. These observations argue against the possibility
that overexpressed SAD-B kinase might pleiotropically
phosphorylate noncognate substrates resulting in
changes of spontaneous mEPSC activity in cultured hip-
pocampal neurons. We therefore believe that the effect
of SAD-B overexpression on spontaneous mEPSC ac-
tivity reflects a physiological function of SAD kinase in
nerve terminals, namely the regulation of spontaneous
activity. However, we speculate that, like other serine/
threonine kinases, SAD kinase has other targets in addi-
tion to RIM1, including candidates localizing on SVs
and/or active zones. Molecular and biochemical ap-
proaches are currently under way to identify and vali-
date additional SAD-B substrates and assess their con-
tribution to spontaneous mEPSC activity.
The present results also suggest that SAD kinase reg-
ulates neurotransmitter release at least at a step of the
docking and/or priming of SVs in presynaptic nerve ter-
minals, which is consistent with the results presented
here showing tight association of SAD-B with the pre-
synaptic cytomatrix. Indeed, the presynaptic cytomatrix
is known to contain several synaptic proteins that are in-
volved in docking and/or priming of SVs, such as
Munc18, Bassoon, RIM1, and Munc13-1 (Augustin
et al., 1999; Voets et al., 2001; Schoch et al., 2002; Al-
trock et al., 2003). Among these candidates, we have
identified at least one substrate, the active zone pro-
tein/vesicle priming factor RIM1, that is selectively
phosphorylated by SAD-B (Figure 8 and Figure S7). Sup-
porting evidence that the phosphorylation of RIM1 by
SAD-B is specific includes: (1) SAD-BWT, but not SAD-
BK63R, phosphorylates RIM1 in a region near the
COOH-terminal C2B domain; (2) SAD-B cannot phos-
phorylate another active zone protein/priming factor
Munc13-1; (3) SAD-B localizes at the presynaptic cyto-
matrix together with RIM1 and Munc13-1 in vivo; (4)
SAD-B, like RIM1, is involved in the regulation of neuro-
transmitter release, possibly in vesicle docking and/or
vesicle priming. Recently, it has been reported that
PKA directly phosphorylates serine 413 of RIM1, which
is critical for induction of presynaptic long-term potenti-
ation by RIM1 at cerebellar parallel fiber synapses (Lo-
nart et al., 2003). However, phosphorylation of RIM1 in-
duced by forskolin, an activator of PKA, is not as strong
as that induced by okadaic acid, suggesting that RIM1 is
also phosphorylated by other kinases (Lonart et al.,
2003). Based on our results, another candidate RIM1kinase may be SAD-B. Consistent with this notion, the
region of RIM1 phosphorylated by SAD-B is different
from that targeted by PKA (this study; Lonart et al.,
2003). RIM1 has been shown to play multiple roles in
neurotransmitter release including regulation of the
RRP size, short-term plasticity, and evoked asynchro-
nous release (Calakos et al., 2004). However, it is still
unknown how phosphorylation of RIM1 by PKA, SAD
kinase, and/or other unidentified kinases contribute to
RIM1 function at a molecular level. Understanding the
physiological significance of phosphorylation of RIM1
by SAD kinase will allow insight into the complicated
mechanisms of the late steps of neurotransmitter re-
lease regulated by RIM1 at the active zone.
We have also shown here that microinjection of SCR2
into SCG neurons causes a reduction in both overall
neurotransmitter release and the size of the RRP of
SVs. SCR2 appears to play a role in localizing SAD-B
at synapses of presynaptic terminals (Figure 4). Thus,
we propose a scenario that abnormal localization of en-
dogenous SAD-B and/or disruption of endogenous
SAD-B interaction with unidentified protein(s) in the
presence of SCR2 may result in an inability of SAD-B
to properly phosphorylate substrate(s) such as RIM1
that are essential for proper maintenance of the size of
the RRP. To confirm this scenario, future research
should address whether the SAD-B phosphorylation
site near the C2B domain of RIM1 regulates the size of
the RRP and also which proteins directly bind to
SCR2. Our preliminary experiments show that none
of the known active zone proteins such as RIM1,
Munc13-1, CAST, ELKS, and Bassoon binds to SAD-B
(unpublished observations), and we have preliminary at-
tempts to isolate a SAD-B binding protein(s) by yeast-
two hybrid method, thus far unsuccessful. Other molec-
ular approaches and/or biochemical strategies will be
employed in future research to isolate SCR2 binding
proteins.
Genetic studies in C. elegans clearly demonstrate that
SAD-1 regulates synapse formation, particularly synap-
togenesis (Crump et al., 2001). More recently, KO analy-
sis of murine SAD kinases demonstrates that SAD ki-
nases regulate axon/dendrite polarization (Kishi et al.,
2005). As presented in Figures S3 and S4, SAD-1 func-
tion in neurotransmitter release from mature synaptic
terminals does not appear to require prior developmen-
tal changes. The discrepancy may indicate a possible
function of SAD-B such that endogenous SAD kinase
activity is required for axon/dendrite polarization in im-
mature neurons but not for maintaining mature axon/
dendrite polarization in established neurons. In the ab-
sence of mature defects in axon/dendrite polarization
observed under our conditions, one could argue that
our studies reveal another significant function of SAD ki-
nase, the regulation of neurotransmitter release, at ma-
ture synapses. In this regard, our findings are in agree-
ment with conclusions derived from the functional
analysis on synaptobrevin/VAMP, RIM1, and Bassoon
KO mice (Schoch et al., 2001; Altrock et al., 2003; Cala-
kos et al., 2004). In these KO mice, neurotransmitter re-
lease is significantly impaired, whereas synapse forma-
tion and gross ultrastructure remain intact. Of course,
we cannot currently rule out the possibility that a subtle
developmental change might occur that could not be
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Furthermore, it is also currently unknown why the previ-
ously observed phenotypes in C. elegans were not rep-
licated under our conditions, but we speculate that this
could be explained by specific levels of SAD kinase
overexpression, effects of endogenous SAD kinases,
the difference between species, developmental roles
of SAD kinases, or a lack of the appropriate signals in
our neuronal culture system that may be present at
whole animal levels.
In summary, we have demonstrated that SAD-B,
a novel SV- and active zone cytomatrix-associated pro-
tein kinase, is involved in the regulation of neurotrans-
mitter release, perhaps via phosphorylation of the active
zone protein and vesicle priming factor RIM1. Given the
results presented in this paper, it is likely that SAD ki-
nase regulates not only neurotransmitter release, but
also formation of the active zone itself via phosphoryla-
tion of other crucial components for active zone assem-
bly. In addition, SAD kinase is involved in neuronal polar-
ization during development (Kishi et al., 2005), although
the relationship of this function to the regulation of neu-
rotransmitter release in adult neurons described here re-
mains to be determined. Thus, the identification and
functional characterization of candidate effector sub-
strates as well as upstream activators for SAD kinase
will likely shed new light on our understanding of regula-
tory mechanisms governing the structure and function
of the presynaptic active zone in both developing and
mature neurons.
Experimental Procedures
Molecular Cloning of SAD-A and SAD-B
Partial cDNA sequences of human SAD-A (AJ006701) and human
SAD-B (AB058714) were identified in the EST database by a BLAST
search with C. elegans SAD-1 kinase sequence. The cDNA probes
for human SAD-A (bp 214–734) and SAD-B (bp 190–882) were cloned
from a human brain total RNA by RT-PCR with oligonucleotides de-
signed based on the human sequences. To obtain full-length SAD-A
and SAD-B, we screened a human brain cDNA library in l ZAPII
(Stratagene) with the cDNA probes. The full length in pBluescript
(Stratagene) was used as the template for PCR to prepare various
constructs.
Abs
Rabbit antisera against SAD-B were raised against GST-SAD-B (aa
450–521; the anti-SAD-B Ab and aa 548–720; the anti-SCR2 Ab)
and affinity purified as previously described (Deguchi-Tawarada
et al., 2004). The polyclonal anti-CAST Ab was obtained as de-
scribed (Takao-Rikitsu et al., 2004). The polyclonal anti-NMDA re-
ceptor 2B (Chemicon), monoclonal synaptophysin (Chemicon),
monoclonal anti-Myc (9E10) (Roche), monoclonal anti-Bassoon
(StressGen), monoclonal anti-synaptotagmin I (WaKo Pure Chemi-
cal Industries, Osaka, Japan), and monoclonal anti-PSD-95/SAP90
(Transduction Laboratories) Abs were purchased from commercial
sources.
Expression Vectors
Expression vectors were constructed in pGEX (Amersham Biosci-
ence), pMALc2 (New England Biolabs), pEGFPC1 (CLONTECH Lab-
oratories, Inc.), pCIneo-Myc, and pCAEGFP (Niwa et al., 1991) by
standard molecular biological methods. The following constructs
of SAD-B contain the following aa residues: EGFP-SAD-B-1 (aa
1–stop), EGFP-SAD-B-2 (aa 1–294), EGFP-SAD-B-3 (aa 1–400),
EGFP-SAD-B-4 (aa 295–stop), EGFP-SAD-B-5 (aa 450–stop),
EGFP-SAD-B-6 (aa 548–720), Myc- and MBP-kinase domain of
SAD-B (aa 1–294). Myc- and EGFP-SAD-B-1K63R and Myc- and
MBP-kinase domain of SAD-BK63R and T189A/S193A were generatedby site-directed mutagenesis with a GeneTailor Site-Directed Muta-
genesis System (Invitrogen) according to the manufacturer’s in-
structions. GST- and MBP-fusion proteins were produced and puri-
fied according to the manufacturer’s instructions.
Recording mEPSC
Culture of hippocampal neurons was prepared as described previ-
ously (Hennou et al., 2003). We used the lipofectamine2000 (Invitor-
gen) for the electrophysiological analysis. To measure the transfec-
tion efficiency of the lipofectamine2000 protocol, we measured the
ratio of EGFP-expressing neuron when the EGFP-tagged protein
was transfected to the neurons by the lipofectamine2000 protocol
by the fluorescent microscope and FACS. 50%–60% of the neuron
was EGFP detectable by a fluorescent microscope, and 80%–90%
of the neurons was EGFP detectable by the FACS methods. For
the mEPSC recording, the culture medium was exchanged for a sa-
line solution containing 168 mM NaCl, 2.4 mM KCl, 2 mM or 10 mM
CaCl2, 1 mM MgCl2, 10 mM glucose, 10 mM HEPES, and 0.5 mM TTX
(pH 7.3). Electrodes (2–4 MU tip resistance) were filled with the
whole-cell pipette solution containing 120 mM K-acetate, 20 mM
KCl, 0.1 mM CaCl2, 5 mM MgCl2, 0.2 mM EGTA, 5 mM ATP, and 10
mM HEPES (pH 7.3). Whole-cell recording configuration was
achieved from the GFP-expressing neurons by using an EPC-7 am-
plifier (HEKA, Germany) and a Digidata 1200 acquisition board (Axon
Instrument). Membrane potential was clamped at 260 mV, and sig-
nals were filtered at 10 kHz with gain set at 0.5 mV/pA for 40 s record-
ing periods. In all instances, the cells were excluded from analysis if
a leak current >300 pA was observed. Membrane resistance (Rm),
series resistance (Rs), and membrane capacitance (Cm) were moni-
tored. Only recordings with Rm >100 MU and Rs <20 MU were in-
cluded for analysis. Mean Rm, Rs, and Cm were not different (p >
0.05) among or within the cells in which comparisons were made.
CNQX (50 mM), an AMPA receptor antagonist, was applied during
a subset of recordings to determine that detected mEPSC events
were AMPA receptor mediated. Measurement of the frequency
and amplitude of mEPSC were performed for a period of 40 s.
mEPSCs were detected by setting the amplitude threshold to back-
ground noise level 3 3. Data from each group were then averaged,
and statistical significance was determined by Student’s t test. p <
0.05 was considered to be statistically significant. All electrophysio-
logical experiments were performed from at least two different plat-
ings of neurons from two different transfections.
SCG Neurons Culture, Immunocytochemistry,
and Electrophysiological Recordings
A culture of SCG neurons was prepared as described previously
(Mochida et al., 1994). For immunocytochemistry of SAD-B, Bas-
soon, and synaptophysin, we fixed SCG neurons cultured for 5–6
weeks and stained them as described above for hippocampal neu-
rons. EPSP recording and injection of the recombinant proteins
were performed as described previously (Mochida et al., 1994,
1998a). Collected electrophysiological data with software written
by the late L. Tauc (Centre National de la Recherche Scientifique,
Gif-sur-Yvette, France) were analyzed with Origin (Microcal Soft-
ware, Inc.). The peak amplitudes of EPSP were averaged. The resul-
tant values were smoothed by an eight-point moving average algo-
rithm and plotted against recording time with t = 0 indicting the
presynaptic injection. For paired-pulse recordings, the membrane
potential was held at280 mV. For each neuron pair, three recordings
were performed for each interval of two stimuli and then averaged.
To measure the RRP size, we puff applied 0.5 M sucrose to presyn-
aptic neurons every 5 min (Mochida et al., 1998b). The integral value
of sucrose responses was averaged and normalized.
Phosphorylation Experiments
Various Myc-tagged SAD-B fragments overexpressed in HEK293
cells were immunoprecipitated with the anti-Myc Ab. The kinase ac-
tivity of the immunoprecipitated proteins was measured by incuba-
tion at 30ºC for 30 min in a reaction buffer (50 ml) containing 50 mM
Tris-HCl (pH 7.5), 0.1% Triton X-100, 1 mM dithiotheitol, 100 mM
NaCl, 10 mM MgCl2, and 1 mCi of [g-
32P] ATP (Amersham). The reac-
tion was stopped with 25 ml of 33 SDS-PAGE sample buffer. The su-
pernatant was subjected to SDS-PAGE, followed by autoradiogra-
phy and Coomassie Brilliant Blue staining.
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der the same condition as described above. For analysis of RIM1
and Munc13-1 phosphorylation, various GST-fusion proteins of
RIM1 and Munc13-1 indicated were incubated with MBP-SAD-B
KDwild or K63R and analyzed as described above.
Other Procedures
Subcellular fractionation of rat brain and solubilization of SAD-B
from the P2 fraction were performed as described previously (Oht-
suka et al., 2002). The methods for primary cultured neuron, trans-
fection, immunocytochemistry, immunohistochemistry, immuno-
electron microscopy, and immunoaffinity purification are described
in the Supplemental Data.
Supplemental Data
The Supplemental Data for this article is available online at http://
www.neuron.org/cgi/content/full/50/2/261/DC1/.
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